01—Abstract
Summary
Summary of the 10-Q filed May 1, 2025. Cited figures are marked; the original filing is the authoritative source.
Linde plc's first-quarter 2025 10-Q shows a company holding sales flat at $8,112 milliona versus $8,100 million a year earlier, while reported operating profit rose 4% to $2,184 million (26.9% margin) and reported diluted EPS grew 5% to $3.51.
Growth was driven by price attainment (+2%) and productivity initiatives, which offset a 1% volume decline and a 3% currency headwind from the weaker Brazilian real, Mexican peso and euro. Adjusted operating profit, which excludes Linde AG merger purchase accounting and $55 millionb of cost reduction charges, rose 4% to $2,438 million (30.1% margin), and adjusted diluted EPS rose 5% to $3.95. Cash generation and capital deployment were strong.
Operating cash flow increased 11% to $2,161 million, while capital expenditures rose to $1,270 millionc, driven by new plant investment against a backlog of large projects of about $7.0 billion. Linde returned roughly $1.8 billion to shareholders through $1,111 million of share purchases and $708 million of dividends, and it funded the gap with net new debt. Total debt climbed to $23.9 billion from $21.6 billion after a February 2025 euro-denominated bond issuance, and cash rose to $5.3 billion.
The main investor watch items are the Russia-related legal exposure and the company's rising leverage. Linde carries $1.8 billiond in recorded liabilities tied to the RusChemAlliance dispute, plus contingent liabilities of $1.1 billion and $0.7 billion for the Russian claims and Amur GPP matters, and it expects no material earnings impact. Reported net income attributable to Linde rose 3%, and the reported effective tax rate increased to 23.4% due to lower share-based compensation tax benefits.
02—Key points
Key Highlights
- Sales were flat at $8,112 million: price/mix added 2%, but volume fell 1% and currency subtracted 3%, with acquisitions adding 1%.
- Reported operating profit rose 4% to $2,184 million (26.9% margin), and adjusted operating profit rose 4% to $2,438 million (30.1% margin).
- Diluted EPS was $3.51 on a reported basis (+5%) and $3.95 adjusted (+5%), helped by lower diluted share count (476.3 million vs. 485.6 million).
- Operating cash flow grew 11% to $2,161 million, while capex increased 21% to $1,270 million, reflecting backlog-driven plant investment.
- Total debt rose to $23.9 billion from $21.6 billion after €2.5 billion of February 2025 notes issuance, and the company retained $6.5 billion of undrawn revolving credit facilities.
- Shareholder returns totaled about $1.8 billion in Q1 ($1.1 billion in buybacks and $708 million in dividends); the quarterly dividend rose 8% to $1.50 per share.
- Russia exposure remains material: $1.8 billion of recorded liabilities tied to the RusChemAlliance dispute, plus $1.1 billion and $0.7 billion in contingent liabilities for Russian claims and Amur GPP matters.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-QQ1 FY2025filed May 1, 2025Financial Statements
Q1 FY2025 against Q1 FY2024
| Line item | Q1 FY2025Q1 FY2024 | Change |
|---|---|---|
| Revenue | $8.11B$8.10B | +0.1% |
| R&D Expenses | $38.00M$38.00M | 0.0% |
| SG&A Expenses | $786.00M$860.00M | −8.6% |
| Operating Income | $2.18B$2.10B | +4.2% |
| Net Income | $1.67B$1.63B | +2.8% |
| EPS (Basic) | $3.53$3.38 | +4.4% |
| EPS (Diluted) | $3.51$3.35 | +4.8% |
| Shares Outstanding (Basic) | 473.30M481.95M | −1.8% |
| Shares Outstanding (Diluted) | 476.26M485.59M | −1.9% |
05—Questions
Frequently Asked Questions
Why did reported operating profit grow only 4% when sales were flat?
Operating profit benefited from higher pricing (+2% to sales) and productivity initiatives, which more than offset cost inflation, lower volumes, currency translation and $55 million of cost reduction charges. Lower Linde AG purchase accounting amortization (D&A fell $39 million) also helped reported results.
How much did Linde spend returning capital to shareholders in Q1 2025?
Linde repurchased $1,111 million of ordinary shares and paid $708 million in dividends, for about $1.8 billion in total. The company has $10.8 billion remaining under its $15.0 billion 2023 share repurchase program, and the quarterly dividend increased 8% to $1.50 per share.
How significant is the Russia-related legal exposure?
Linde has recorded roughly $1.8 billion in liabilities tied to the RusChemAlliance dispute and carries additional contingent liabilities of about $1.1 billion (Russian claims) and $0.7 billion (Amur GPP matters). Management does not expect a material adverse earnings impact, but timing of resolution is difficult to estimate and outcomes could significantly affect reported results in any given period.
Is Linde's balance sheet getting more leveraged?
Yes. Total debt increased to $23.9 billion from $21.6 billion, driven by new notes issued in February 2025 and higher commercial paper. Even so, Linde reports no financial maintenance covenants on its credit agreements, no borrowings under its $5 billion and $1.5 billion revolving facilities, and continued strong ratings from Moody's and S&P.
What is driving the higher capital expenditures?
Capex rose $222 million to $1,270 million, mainly for new plant and production equipment supporting backlog growth. Linde's large project backlog under construction is approximately $7.0 billion, and the company's remaining performance obligations for minimum purchase requirements and plant sales total about $58 billion.
06—Continue